Brief: Casi Pharmaceuticals Inc Says As Of Dec. 31, 2021, It Had Cash And Cash Equivalents Of $38.7 Mln
28/03/2022 12:20
March 28 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS INC - AS OF DECEMBER 31, 2021, CASI
HAD
CASH AND CASH EQUIVALENTS OF $38.7 MILLION
Source text for Eikon: ID:nPn7HVPD0a
Further company coverage: CASI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary